PHAXIAM Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.3%.

Top 25 shareholders own 41.27% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
25.1%	EPIC Bpifrance, Asset Management Arm	2,500,000	€4.2m	0%	5.03%
4.77%	Go Capital SAS	475,606	€800.0k	1,500%	29.72%
4.73%	Tikehau Investment Management SAS	471,777	€793.5k	0%	0.46%
2.06%	Akkadian Partners S.A.	205,695	€346.0k	0%	no data
0.96%	Aviva Investors Global Services Ltd.	95,956	€161.4k	468%	no data
0.54%	SAS Helea Financière	54,375	€91.5k	0%	no data
0.54%	Auriga Partners	54,181	€91.1k	0%	20.39%
0.43%	Recordati Orphan Drugs	43,103	€72.5k	0%	no data
0.31%	Valentine Gouedard Comte	31,193	€52.5k	0%	no data
0.26%	Solys	26,189	€44.0k	0%	no data
0.24%	Myropola	24,042	€40.4k	0%	no data
0.17%	Bpifrance Participations SA	17,418	€29.3k	0%	no data
0.16%	MP Deloche & Associates SARL	16,100	€27.1k	0%	no data
0.15%	Paminove	15,376	€25.9k	0%	no data
0.15%	Sc Roc De Lou	15,108	€25.4k	0%	no data
0.14%	Mathieu Bigois	13,700	€23.0k	0%	no data
0.12%	Financiere Saint Romain	11,854	€19.9k	0%	no data
0.12%	Sofidu	11,854	€19.9k	0%	no data
0.09%	Jacques Tcheng	9,016	€15.2k	0%	no data
0.076%	Guy Rigaud	7,576	€12.7k	0%	no data
0.06%	Gestys SA	6,000	€10.1k	0%	0.4%
0.055%	Thibaut Fayet	5,486	€9.2k	0%	no data
0.034%	Friedland Gestion	3,375	€5.7k	0%	0.11%
0.026%	Bernard Linage	2,626	€4.4k	0%	no data
0.01%	Philippe Archinard	1,030	€1.7k	0%	no data